Coronavirus

Flu cases surge in the UK hospitals while China battles human metapneumovirus

Flu Season: New data from the NHS shows rapid rise in flu cases across the UK, whilst across the world, china continues its battle against human metapneumovirus virus.

REACT study: Women in UK have higher chance of long COVID

New data from the ongoing REACT study found that over two million people in the UK are known to have experienced long COVID.

Delta variant responsible for one in five US COVID cases

The Delta variant, originating in India, is now responsible for one in five US COVID cases, according to new information from Dr Anthony Fauci.

Study finds COVID increased “forced labour” in garment supply chains

This study examined 302 factories, finding that forced labour and exploitation increased in garment supply chains across Ethiopia, Honduras, India and Myanmar.

UK Government to sell NHS patient data to third parties

The UK Government will permanently transfer all NHS patient data to a database tomorrow (23 June), which will then be sold to third parties - today is the last chance to opt-out.

Learning from COVID-19 and the continuing malaria fight

Michelle Davis, Head of External Relations at Malaria Consortium, shares with us what we need to know about learning from COVID-19 and the continuing fight against malaria.

WHO says Delta variant will be globally dominant

The World Health Organisation on Friday (18 June) said that the Delta variant, originating in India, would be globally dominant due to "significantly increased transmissibility".

Canada: Infection & immunity focus

The Canadian Institutes of Health Research, part of the Government of Canada, has an Institute of Infection and Immunity. Here, we gain a flavour of what they do.

Hospitals of the future: The importance of digital transformation skills

Here, Fraunhofer Germany discuss how COVID-19 has driven the adoption of digital health technologies, and offers solutions aiding healthcare professionals to keep up.

CureVac vaccine performs at 47% efficacy in latest trial

The German-made CureVac vaccine has given a result of 47% efficacy, much lower than expected - now, the proposed delivery of 225 million doses to the EU is at risk.

COVID-19 in Africa: Where are we?

Open Access Government caught up with Dr Mary Stephen, Public Health Expert at the World Health Organization African Region, provides an update on the COVID-19 outbreak in Africa.

REACT study: Scientists say 90% of UK virus cases are Delta variant

The latest REACT figures show that 90% of UK virus cases are now the Delta variant, with the highest rates of infection in those...

New ‘superfungus’ emerges in Brazil during pandemic

Exhausted medical staff in Brazil have enough to deal with when it comes to COVID-19 - now, a new 'superfungus' has evolved beyond drug treatment.

COVID vaccines to be mandatory for care home workers

The UK Government will make COVID vaccination mandatory for care home workers, with the possibility that NHS workers will also be required to get the jab.

Delta variant twice as likely to cause COVID hospitalisation

A Scottish study, published in The Lancet, found the Delta variant was twice as likely as the Alpha variant to cause COVID hospitalisation.

Towards a long-term Mental Health Strategy

Chairs of the Parliament’s Coalition for Mental Health and Wellbeing demand immediate action to address the growing mental health crisis and the creation of a long-term Mental Health Strategy.

PHE study finds AstraZeneca vaccine 92% effective against Delta variant

Public Health England found that two doses of the Pfizer and AstraZeneca vaccine could still keep patients with the Delta variant out of hospital - but both are now less able to stop infection in the first place.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders